Today: 10 June 2026
Nebius Group (NBIS) stock falls as insider sale filings surface ahead of Jan. 2 trading restart
1 January 2026
2 mins read

Nebius Group (NBIS) stock falls as insider sale filings surface ahead of Jan. 2 trading restart

NEW YORK, December 31, 2025, 20:44 ET — Market closed

Nebius Group N.V. shares ended down 1.7% at $83.71 on Wednesday, after U.S. filings showed several insiders planned sales of the company’s Class A ordinary shares in early January. The stock traded between $82.94 and $86.41, with about 7.1 million shares changing hands.

The disclosure matters because Nebius has been a high-beta proxy for the AI infrastructure buildout, where sentiment can swing quickly on any sign of incremental supply. Investors in the group have also been focused on dilution risk and funding needs as the company ramps capacity.

Timing adds to the sensitivity. U.S. markets are closed on Thursday for New Year’s Day and reopen Friday, raising the odds that any orders tied to those planned sales could hit when liquidity is still rebuilding after the holiday.

A set of Form 144 notices — filings used to signal a proposed sale of securities under SEC Rule 144 — listed planned transactions largely scheduled for Jan. 2, 2026. Arkadiy Volozh proposed selling 41,000 shares (about $3.59 million using an indicative price), while Nave Ophir and Elena Bunina each proposed selling 2,300 shares (about $201,457 apiece) and Kira Radinsky proposed selling 500 shares (about $43,795), the filings showed.

Rule 144 governs the resale of restricted or “control” securities held by affiliates, and Form 144 is the notice that can accompany those sales. The filings are not proof a sale has happened, but they can flag potential near-term supply for the market to absorb. Thomson Reuters

The backdrop was risk-off year-end trading across U.S. equities. The S&P 500 fell 0.74% and the Nasdaq Composite slid 0.76% on Wednesday, with technology among the weakest sectors, according to Reuters. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low. Reuters

Nebius, based in Amsterdam, is part of a crop of “neocloud” providers that rent out high-performance computing capacity, including Nvidia graphics processing units used to train and run AI models. The company has said demand for AI compute has been strong enough to create capacity constraints even for hyperscalers, and Reuters has previously cited CoreWeave as a larger rival in the same market. Reuters

The company has also tied its growth narrative to big-ticket customer contracts. In November, Nebius said it signed a roughly $3 billion agreement with Meta to provide AI infrastructure over five years, and Reuters has reported it previously struck a $17.4 billion deal with Microsoft.

Funding and capital intensity remain part of the equity story. Nebius said in September it would raise $3 billion — including a share offering and convertible notes — to fuel expansion, and Reuters reported the company emerged from a deal to split the assets of Russian tech firm Yandex.

With the stock closing near the lower end of Wednesday’s range, traders will be watching whether the $83 area holds when markets reopen. The mid-$80s zone is also in focus after the day’s high, with investors looking for signs that selling pressure is fading rather than building.

Before the next session, attention is likely to center on whether the proposed insider transactions show up in tape action on Jan. 2 and how quickly buyers step in. Because the filings described “sell-to-cover” transactions tied to compensation in several cases, investors will also parse whether the flow looks mechanical or broader. SEC

Beyond the immediate flow, the next scheduled checkpoints are operational and financial. Nasdaq’s earnings calendar lists Feb. 18, 2026 as an estimated reporting date, and investors will be listening for any update on spending and capacity plans that can move cash burn and dilution expectations.

Nebius has said in a prior SEC filing that GPU services under its Meta agreement would be deployed in two tranches during December 2025 and February 2026, putting execution on delivery timelines back on the near-term watch list as 2026 begins.

Stock Market Today

  • Sensex Rises 1,000 Points in 2 Days as Nifty Crosses 23,400 on Oil Price Drop and Banking Gains
    June 10, 2026, 4:23 AM EDT. The Indian stock market rallied sharply over two sessions, with Sensex gaining 1,010 points to 74,535 and Nifty crossing 23,400 amid continued Iran-US conflict. Oil prices fell below $92 a barrel, easing inflation concerns and outweighing geopolitical risks in the Middle East. Leading gains were financial and consumer sectors, notably ICICI Bank and Hindustan Unilever, while metals lagged. The market shrugging off tensions was attributed to sustained oil price softness and limited impact on economic fundamentals. Despite broader market pressure, the rise added over Rs 5 lakh crore to total market capitalization, highlighting investors' focus on resilient banking and FMCG sectors amid global uncertainties.

Latest articles

Nvidia Finally Got Apple’s AI Nod. The Stock Still Couldn’t Catch a Bid

Nvidia Finally Got Apple’s AI Nod. The Stock Still Couldn’t Catch a Bid

10 June 2026
Nvidia shares slipped 0.2% to $208.19 Tuesday despite Apple confirming it will use Nvidia GPUs in Google Cloud for its most demanding AI workloads, as investors weighed the endorsement against a tech sector selloff, unclear revenue impact, and rising competition from Google and Intel, while China’s new $295 billion data-center plan threatens to squeeze out foreign chipmakers.
Intel Shares Face Early Test After Google-Driven Spike

Intel Shares Face Early Test After Google-Driven Spike

10 June 2026
Intel shares fell 2.1% to $107.92 after Monday’s 11.2% surge on a reported Google AI-chip order, as investors weighed the unconfirmed deal’s potential to boost Intel’s foundry business against a broader tech selloff; Reuters could not verify the report, and Intel declined comment.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.06.2026

10 June 2026
LIVEMarkets rolling coverageStarted: June 10, 2026, 4:00 AM EDTUpdated: June 10, 2026, 4:34 AM EDT Sensex Rises 1,000 Points in 2 Days as Nifty Crosses 23,400 on Oil Price Drop and Banking Gains June 10, 2026, 4:23 AM EDT. The Indian stock market rallied sharply over two sessions, with Sensex gaining 1,010 points to 74,535 and Nifty crossing 23,400 amid continued Iran-US conflict. Oil prices fell below $92 a barrel, easing inflation concerns and outweighing geopolitical risks in the Middle East. Leading gains were financial and consumer sectors, notably ICICI Bank and Hindustan Unilever, while metals lagged. The market shrugging
Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

10 June 2026
U.S. stock futures fell after hours and oil rose as U.S. strikes on Iran fueled risk-off sentiment, deepening losses in tech shares and raising investor caution ahead of Wednesday’s key inflation report, with fears of Fed rate hikes and volatility from the upcoming SpaceX IPO adding pressure.
Keel Slides After $458 Million AI Data-Center Debt Deal Launch

Keel Slides After $458 Million AI Data-Center Debt Deal Launch

10 June 2026
Keel Infrastructure shares plunged 4.24% to $5.42 after closing a $458 million convertible debt sale, reviving investor fears of future dilution even as the company boosts funding for AI-focused data-center projects; shares slipped further to $5.32 after hours on more than double average volume, reflecting concerns over execution risks and the impact of new financing.
Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading
Previous Story

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop